LRCX Stock: The Math Behind The Upside
Lam Research (LRCX) stock trades at $299.15 per share, a market cap of $373.9B, and 55.7 times trailing earnings. Is that a fair price, or is there more going on here?
Where LRCX Sits Today
- Valuation: P/E of 55.7 versus a 3-year average of 26.7 and a 3-year high of 55.7.
- Revenue: Revenue grew 26.5% over the last 12 months, with a 3-year CAGR of 7.5%.
- Net Margin: Running at 30.9% LTM, against a 3-year average of 27.0% and a 3-year peak of 30.9%.
While the table below shows the same picture in one place, you can internalize LRCX’s current state better with a more detailed financial picture.
| LRCX | |
|---|---|
| Sector | Information Technology |
| Industry | Semiconductor Materials & Equipment |
| P/E Ratio | 55.7 |
| P/E Ratio 3Y Avg | 26.7 |
| LTM* Revenue Growth | 26.5% |
| 3Y Avg Revenue Growth | 7.5% |
| LTM* Net Margin | 30.9% |
| 3Y Peak Net Margin | 30.9% |
| 3Y Avg Net Margin | 27.0% |
*LTM: Last Twelve Months
Revenue Compounding Does The Work
LRCX has accelerated recently, but at these levels, gravity eventually takes over. We will not extrapolate peak performance, and instead, apply a structural fade to project 22.6% annually.
Even with these conservative guardrails, compounding moves the earnings base enough to deliver the upside here. Margins and multiples are not asked to stretch.
The 3-Year Math
A straightforward scenario, not a forecast. Here is what the numbers look like.
- Revenue grows at 22.6% annually (applying a structural fade to recent peak acceleration), and reaches $39.9B from $21.7B today.
- Net Margin eases from 30.9% to 29.8% as peak-level margins pull back toward the 3-year average of 27.0%.
- Earnings combine the two. The base moves to roughly $11.9B from $6.7B today, about a 77% jump.
- P/E eases from 55.7 to 50.2, a partial reversion from above-average levels back toward the 3-year average of 26.7.
Apply the projected multiple to the projected earnings base: stock price lands near $476.83, a market cap of $595.9B against $373.9B today. That is roughly 59% above where the stock trades now.
Revenue compounding might be the key to LRCX’s upside going forward. But did the same lever drive its recent move or was it something different?
What Has To Be True
The scenario assumes growth of 22.6% annually, intentionally faded below the LTM 26.5% pace. What has to be true is that growth settles at or above this modest rate. If it collapses entirely, the multiple in our scenario becomes hard to defend.
One thing to watch: LRCX’s multiple is currently above its 3-year average. The scenario builds in partial mean-reversion, but if the P/E compresses more violently than assumed, some upside evaporates.
Worth flagging: LRCX share count is down about 7.4% over the last 3 years. That buyback pace means even flat net income translates to rising EPS, compounding with whatever the main scenario delivers.
The 3-year horizon is a convenience. Whether this plays out over 3 years or 5, the stock price is likely to respond in a similar direction, as long as the trajectory holds.
When One Stock Isn’t The Whole Answer
A careful 3-year case on a single name is still a concentrated bet, as analysis of its volatility during past market crises shows. Investors who build analyses like this on individual positions often want the same framework running across a diversified book – partly for discipline, partly because even the cleanest single-stock thesis can break for reasons the math does not capture.
The Trefis High Quality (HQ) Portfolio combines the analytical rigor with forward looking view across 30 stocks, with a consistent selection framework and a sizing and rebalancing discipline designed to deliver upside without the single-name risk you just read through here.
By selecting 30 high-conviction stocks, the HQ strategy has historically outpaced the S&P 500, S&P Mid-cap, and Russell 2000.